Therefore, we measured the serum concentration of IL-33 and Th2 cytokines (IL-4 and IL-13) in patients with SS, IgG4-RD, and healthy controls by ELISA. This evidence concerns the gene IL33 and immunoglobulin G4-related sclerosing disease.